Head-to-head comparisons of medication uses, side effects, warnings, and more.
Ilumya (tildrakizumab)
Skyrizi (risankizumab)
Ilumya (tildrakizumab)
Skyrizi (risankizumab)
Summary of Ilumya vs. Skyrizi
Summary for Interleukin-23 antagonist
Prescription only
Ilumya (tildrakizumab or tildrakizumab-asmn) is used to treat plaque psoriasis in adults. It's a type of monoclonal antibody called an interleukin-23 antagonist. It works by lowering inflammation in the skin. This medication is given as an injection under the skin every 3 months by a healthcare professional. Some people might have upper respiratory tract infections as a side effect. Ilumya (tildrakizumab) is only available as a brand-name medication.